IP Library Granted Patent US 8,109,932
Granted Patent B2
US 8,109,932 · App. 11/643,390 · Granted Feb 7, 2012

Bone regeneration device for bones, and method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,109,932
App. No.
11/643,390
Granted
Feb 7, 2012
Kind
B2
Abstract

A method of stimulating bone regeneration in a discontinuous section of a long bone in a subject requiring same, comprising the step of applying to said discontinuous section of the bone an effective vacuum for an effective length of time. A device for carrying out the method consisting of a sealable tubular-shaped sleeve or cuff that fits snugly and sealably around the bone section to be treated and that can be evacuated via a port that is integral to the sleeve or port.

Claims (20)

1. A method of stimulating new bone formation in a bone with a discontinuity defect, the method comprising:

sealing a sleeve or cuff having a port to a first portion of the bone located above the discontinuity defects and a second portion of the bone located below the discontinuity defects, the port being in fluid communication with the discontinuity defect;

fluidly connecting a vacuum pump to the port;

applying vacuum pressure, produced by the vacuum pump, to the discontinuity defect through the port; and

responsive to the vacuum pressure reaching a predetermined level, sealing the port to maintain the vacuum pressure at the discontinuity defect for an effective period of time.

2. The method according to claim 1 , wherein the bone is selected from a group comprising of a femur, a clavicle, ribs, humerus, ulna and radius, carpal and metacarpal bones and their phalanges, tibia, fibula, and tarsal and metatarsal bones and their phalanges.

3. The method according to claim 1 , wherein an effective amount of vacuum pressure is greater than or equal to about 30 in Hg.

4. The method according to claim 1 , wherein the effective period of time is about four weeks.

5. The method according to claim 1 further comprising determining the effective period of time based on a medical condition being treated and a degree of bone regeneration required.

6. The method according to claim 1 further comprising determining the effective period of time by radiographically viewing bone regeneration in the bone.

7. The method according to claim 1 , wherein applying the vacuum pressure to the discontinuity defect further comprises applying the vacuum pressure to the bone through the sleeve or cuff.

8. The method according to claim 1 further comprising:

surgically exposing the bone prior to positioning the sleeve or cuff, thereby creating a surgical wound; and

closing the surgical wound after positioning the sleeve or cuff.

9. The method according to claim 1 further comprising:

measuring the vacuum pressure applied to the bone;

reapplying vacuum pressure as necessary during the effective period of time to maintain an effective amount of vacuum pressure;

determining the effective period of time by radiographically viewing bone regeneration in the bone;

ceasing the application of vacuum pressure following bone regeneration; and

removing the sleeve or cuff following the effective period of time.

Assignments (11)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY AGREEMENT Recorded Nov 8, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 027194/0447 →
SECURITY AGREEMENT Recorded Nov 7, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027185/0174 →
RELEASE OF SECURITY INTEREST Recorded May 30, 2008
From: CITIBANK, N.A.
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; KCI HOLDING COMPANY, INC.; KCI LICENSING, INC.; KCI INTERNATIONAL, INC.
Reel/Frame 021018/0130 →
SECURITY AGREEMENT Recorded Aug 2, 2007
From: KCI LICENSING, INC.; KINETIC CONCEPTS, INC.; KCI USA, INC.; KCI HOLDING COMPANY, INC.; KCI INTERNATIONAL, INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 019640/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2007
From: LYTINAS, MICHAEL
To: KCI LICENSING, INC.
Reel/Frame 018910/0818 →